Joseph Vazzano
Directeur Financier/CFO chez ABEONA THERAPEUTICS INC.
Fortune : 922 030 $ au 30/06/2024
Postes actifs de Joseph Vazzano
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. | Comptroller/Controller/Auditor | 31/03/2022 | - |
| Directeur Financier/CFO | 14/03/2022 | - | |
| ALLARITY THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/08/2023 | - |
| Independent Dir/Board Member | 01/08/2023 | - | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Directeur/Membre du Conseil | - | - |
| Independent Dir/Board Member | - | - |
Historique de carrière de Joseph Vazzano
Anciens postes connus de Joseph Vazzano
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AVENUE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 15/08/2017 | 08/02/2019 |
| Directeur Financier/CFO | 15/08/2017 | 07/01/2022 | |
| Secrétaire Général | 08/02/2019 | 07/01/2022 | |
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2016 | 01/07/2017 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
| Pernix Therapeutics, Inc. | Corporate Officer/Principal | - | - |
Formation de Joseph Vazzano
| Lehigh University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| 2 | |
| Danemark | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AVENUE THERAPEUTICS, INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| ABEONA THERAPEUTICS INC. | Health Technology |
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Pernix Therapeutics, Inc. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Bourse
- Insiders
- Joseph Vazzano
- Expérience
